Comparison

TPCA-1 European Partner

Item no. TMO-T3049-500mg
Manufacturer TargetMol
CASRN 507475-17-4
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,9929
Formula C12H10FN3O2S
Smiles NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias GW683965,IKK2 Inhibitor IV,TPCA1
Shipping Condition Cool pack
Available
Manufacturer - Targets
IκB/IKK|||Apoptosis|||STAT
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
279.29
Description
TPCA-1 (TPCA1) is an effective and specific IKK-2 inhibitor (IC50: 17.9 nM); shows >22-fold selectivity over IKK-1 and >550-fold selectivity over others kinases and enzymes.
Pathways
Apoptosis|||Stem Cells|||JAK/STAT signaling|||NF-κB
Bioactivity
TPCA-1 is an effective and specific IKK-2 inhibitor (IC50: 17.9 nM); shows >22-fold selectivity over IKK-1 and >550-fold selectivity over others kinases and enzymes.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close